Live Breaking News & Updates on சீனா மாபெரும் மருந்து

Stay updated with breaking news from சீனா மாபெரும் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

eTheRNA immunotherapies opens office in Hong Kong to support and build on its growing activities in China and broader Asia-Pacific


Share this article
Share this article
NIEL, Belgium, Aug. 3, 2021 /PRNewswire/ eTheRNA immunotherapies NV ( eTheRNA or the Company ), a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and infectious diseases, today announces the opening of its new subsidiary, eTheRNA Asia Limited ( eTheRNA Asia ), with offices located in the Sheung Wan area of Hong Kong.
The Asia-Pacific region is growing in importance in the global healthcare sector and this new subsidiary will serve as a focus for eTheRNA s increasing commercial activities in this area. In particular, eTheRNA Asia will focus on supporting business and investor relations in China and especially the relationship between eTheRNA and its strategic partner, China Grand Pharmaceutical and Healthcare Holdings Ltd ( CGP ). CGP and eTheRNA s relationship is centred on their joint venture company, Nanjing AuroRNA Biotechnology Company Limited. ....

Hong Kong , Sheung Wan , Hong Kong General , Steven Powell , Aurorna Biotechnology Company , Healthcare Holdings Ltd , Therna Asia , China Grand Pharmaceutical , Nanjing Auro , Chief Executive Officer , Healthy China , ஹாங் காங் , ஸ்டீவன் போவல் , சுகாதாரம் ஹோல்டிங்ஸ் லிமிடெட் , சீனா மாபெரும் மருந்து , தலைமை நிர்வாகி அதிகாரி , ஆரோக்கியமான சீனா ,